Novo Nordisk A/S (NVO)

Last Closing Price: 62.08 (2025-04-25)

Weighted-Average Shares Outstanding (Basic) (Annual)

Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.

Novo Nordisk A/S (NVO) had Weighted-Average Shares Outstanding (Basic) of 4.45B for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$42.11B
$14.64B
$6.46B
$35.65B
$23.50B
$18.61B
$-166.46M
$18.44B
$18.44B
$14.64B
$14.64B
$14.64B
$14.64B
$18.61B
$21.38B
Weighted-Average Shares Outstanding (Basic)
4.45B
4.46B
$3.29
$3.28
Balance Sheet Financials
$23.33B
$23.56B
$44.21B
$67.54B
$31.54B
$13.00B
$15.19B
$46.73B
$20.81B
$4.70B
$20.81B
4.46B
Cash Flow Statement Financials
$17.54B
$-18.69B
$1.27B
$2.09B
$2.27B
$183.13M
$331.90M
$-6.40B
--
Fundamental Metrics & Ratios
0.74
--
--
0.38
0.72
84.67%
44.19%
44.19%
50.77%
43.80%
34.78%
$10.70B
--
--
--
0.62
1.09
3.32
109.87
70.38%
311.73%
21.68%
43.31%
$4.66
$2.40
$3.93